Cause & Cure Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.53 M
as on 09-12-2024
- Revenue -22.71%
(FY 2023)
- Profit -31.96%
(FY 2023)
- Ebitda 2.03%
(FY 2023)
- Net Worth 14.79%
(FY 2023)
- Total Assets -23.68%
(FY 2023)
About Cause & Cure
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.53 M.
Gourav Sardana and Deepa Gandhi serve as directors at the Company.
- CIN/LLPIN
U24232HR2011PTC043842
- Company No.
043842
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Sep 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Cause & Cure Private Limited offer?
Cause & Cure Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Nutraceuticals & Dietary Supplements, Mineral Supplement, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines.
Who are the key members and board of directors at Cause & Cure?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gourav Sardana  | Director | 09-Sep-2011 | Current |
| Deepa Gandhi | Director | 21-May-2013 | Current |
Financial Performance of Cause & Cure.
Cause & Cure Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.71% decrease. The company also saw a substantial fall in profitability, with a 31.96% decrease in profit. The company's net worth Soared by an impressive increase of 14.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cause & Cure?
In 2023, Cause & Cure had a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prisma Vision Venture Partners Private LimitedActive 3 years 11 monthsGourav Sardana is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Dec 2023 | ₹1.50 M | Open |
Hdfc Bank Limited Creation Date: 27 Jun 2023 | ₹1.40 M | Open |
Hdfc Bank Limited Creation Date: 30 Oct 2020 | ₹0.63 M | Open |
How Many Employees Work at Cause & Cure?
Unlock and access historical data on people associated with Cause & Cure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cause & Cure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cause & Cure's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
